Delivery Order SPE2DB20D3104-SPE2DB22FV6E8
Award Date
4/13/22
Potential Completion Date
4/14/22
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,296.53, is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through December 2022. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NORVASC 2.5 mg tablets. The contract has a firm-fixed price of $1,792.72 and an ultimate completion date of August 28, 2024. It was awarded as a delivery order, with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract, which is likely part of a larger Indefinite Delivery Contract...
This federal contract award is a delivery order (SPE2DB23FV5E7) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,396.63 firm fixed-price contract is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The award has an ultimate completion date of February 15, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $83,150.57, is for the delivery of 90-count bottles of Norvasc 10 mg tablets, a medication used to treat high blood pressure and chest pain. The contract has a completion date of February 10, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,093.44 firm-fixed-price contract is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The contract is not set aside for any specific business type. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,167.46 firm fixed price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a pharmaceutical product, in support of military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,244.76 firm fixed price delivery order is for the supply of NORVASC 10 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
This federal contract award, worth $4,652.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Norvasc 5 mg tablets, a cardiovascular medication, with a completion date of July 8, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 90 tablets of NORVASC 10 MG for $215,011.72. The order was placed on July 21, 2022 and is scheduled for completion on July 22, 2022. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp is a prime contractor that has received numerous awards from DLA to provide pharmaceuticals, medical supplies,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $2,895.14 firm-fixed-price delivery order is for the supply of 4,565,597,451 units of the prescription drug Norvasc (amlodipine besylate) 5 mg tablets. The contract has an ultimate completion date of August 28, 2024 and does not utilize any set-aside designations. Amerisourcebergen is a major pharmaceutical distributor that...